Form 4: Arteris Inc. Director Receives Restricted Stock
Statement of Changes in Beneficial Ownership
Arteris, Inc. Director Claudia F. Munce acquired 350 shares of common stock as fully vested restricted stock, representing retainer fees elected in lieu of cash.
Summary
- Claudia F. Munce, a Director at Arteris, Inc., acquired 350 shares of common stock on July 5, 2026.
- These shares were received as fully vested restricted stock, representing retainer fees that Ms. Munce elected to receive in shares instead of cash.
- The grant of restricted stock was based on an average trading price of $39.28 per share for the period from May 20, 2026, through July 2, 2026.
- Following this transaction, Ms. Munce beneficially owns 106,764 shares of common stock directly.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this filing as neutral, as it represents a routine compensation transaction for a director rather than a significant strategic or financial event.
Positives
- Director compensation is being paid in equity, aligning management interests with shareholders.
- The transaction involves vested restricted stock, indicating a completed compensation award.
- The reporting person has a significant existing beneficial ownership of 106,764 shares.
Future Outlook
No specific future outlook or guidance is provided in this Form 4 filing, which details a change in beneficial ownership.
Industry Context
StockSavvy.ai notes that the use of restricted stock for director compensation is a common practice in the technology sector, including semiconductor IP companies like Arteris, Inc., to attract and retain talent and align executive interests with long-term shareholder value.
Stakeholder Impact
- Shareholders: The issuance of stock for compensation aligns director interests with shareholders, potentially leading to better long-term decision-making.
- Employees: This transaction does not directly impact employees but reflects standard compensation practices within the company.
- Management: The transaction confirms a standard method of director compensation, indicating no immediate changes to management's compensation structure.
Key Dates
| Date | Description |
|---|---|
| 05/20/2026 | Start of the period for determining the average trading price of Arteris, Inc. common stock for the restricted stock grant. |
| 07/02/2026 | End of the period for determining the average trading price of Arteris, Inc. common stock for the restricted stock grant. |
| 07/05/2026 | Date of the earliest transaction reported and the grant date of the restricted stock. |
| 07/07/2026 | Date the Form 4 was signed by the reporting person's attorney-in-fact. |
Keywords
Arteris Inc., Form 4, SEC Filing, Restricted Stock, Director Compensation, Beneficial Ownership, Claudia F. Munce
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.